Stock Markets Analysis & Opinion

Beacon Roofing Supply (BECN) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.68 per share a year ago....

Fortive (FTV) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.82 per share a year ago. These figures are...

Columbia Sportswear (COLM) came out with quarterly earnings of $1.68 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.31 per share a year ago. These...

Nuance Communications (NUAN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.27 per share a year ago....

Western Union (WU) came out with quarterly earnings of $0.49 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.41 per share a year ago. These figures are adjusted...

Ligand Pharmaceuticals (LGND) came out with quarterly earnings of $1.70 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.31 per share a year ago....

Fiserv (NASDAQ:FISV) came out with quarterly earnings of $0.84 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.71 per share a year ago. These figures are adjusted...

Qorvo (QRVO) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.70 per share. This compares to earnings of $1.69 per share a year ago. These figures are...

Pelatro’s demonstration of its mViva marketing platform at a recent capital markets day revealed the scope of its big data analytics capabilities and interactive user interface. Ease of use by...

This week, The New York Times Company (NYSE:NYT) impressed investors with its latest earnings report. The company posted revenue growth of 4%, comfortably topping estimates on the back of strong...

The Zacks Medical - Instruments industry is highly fragmented, with participants engaged in research and development of new devices for specific therapeutic areas. This FDA-regulated industry...

Exelixis, Inc. (NASDAQ:EXEL) is scheduled to report fourth-quarter 2018 results on Feb 12, after the market closes.Exelixis’ shares have gained 7.6% in the past six months compared with the...

Apple (NASDAQ:AAPL) is not recommended now because of the softening in its key product category. But there’s huge opportunity for the company to grow in the future, as evident from the...

Every week, Zacks stock strategist Tracey Ryniec hosts the Zacks Market Edge Podcast, and is joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your...